Cargando…
Economic results of a palivizumab seasonal prophylaxis using a cohorting software and vial sharing
BACKGROUND: Respiratory syncytial virus is the most important pathogen in lower respiratory tract infection in infants and young children. In high-risk populations it may develop severe, sometimes fatal, lower respiratory tract infections. A proportion of these infants require admission to intensive...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909955/ https://www.ncbi.nlm.nih.gov/pubmed/20609229 http://dx.doi.org/10.1186/1824-7288-36-48 |